BioSig Technologies, Inc.
BSGM
$0.60
-$0.136-18.48%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 58.09% | 64.71% | 53.60% | 13.06% | 28.33% |
| Total Depreciation and Amortization | -7.93% | -23.03% | 0.00% | -19.81% | 1.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,506.33% | -3.13% | -38.02% | 21.84% | -62.74% |
| Change in Net Operating Assets | -642.93% | -16,847.62% | 210.88% | -6.24% | -50.30% |
| Cash from Operations | 61.10% | 69.74% | 76.74% | 28.49% | 22.62% |
| Capital Expenditure | -- | -- | -- | 93.10% | -20.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 93.10% | -20.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -2.34% | -84.59% | -24.57% | 225.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -34.14% | -77.18% | -24.57% | 274.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.54% | 1,155.00% | -78.58% | 62.45% | 79.40% |
